copeptins

glycopeptide third domain of vasopressin precursor along with MSEL-neurophysin; 39 amino acid residues in most mammalian species, 38 in guinea pig; amino acids vary somewhat among species

Also Known As:

Networked: 15 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Struck, Joachim: 5 articles (07/2011 - 04/2007)
2.	Morgenthaler, Nils G: 5 articles (07/2010 - 04/2007)
3.	Bergmann, Andreas: 4 articles (01/2010 - 04/2007)
4.	Davies, Joan E: 3 articles (07/2011 - 04/2007)
5.	Ng, Leong L: 3 articles (07/2011 - 04/2007)
6.	Squire, Iain B: 3 articles (07/2011 - 04/2007)
7.	Dhillon, Onkar S: 2 articles (07/2011 - 04/2007)
8.	Khan, Sohail Q: 2 articles (11/2008 - 04/2007)
9.	Alehagen, Urban: 1 article (01/2016)
10.	Charitakis, Emmanouil: 1 article (01/2016)

Related Diseases

1.	Myocardial Infarction 05/01/2009 - "C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study." 04/24/2007 - "C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study." 11/01/2008 - "C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction." 07/01/2011 - "C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study." 07/01/2010 - "To determine whether C-terminal provasopressin (copeptin) explains the prognostic importance of insulin growth factor binding protein-1 (IGFBP-1) in patients with myocardial infarction and type 2 diabetes. "
2.	Heart Failure 05/01/2009 - "C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study." 11/01/2008 - "C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction."
3.	Acute Coronary Syndrome 04/29/2014 - "The aim of this study was to assess the prognostic performance of C-terminal provasopressin (copeptin), midregional pro-adrenomedullin (MR-proADM), and midregional pro-atrial natriuretic peptide (MR-proANP) in a large prospective cohort of patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). "
4.	Insulin Resistance 07/01/2009 - "The objective of the study was to investigate whether plasma C-terminal provasopressin fragment (copeptin), a surrogate for circulating AVP, was associated with measures of insulin resistance and presence of MetSyn. "
5.	Non-ST Elevated Myocardial Infarction 07/01/2011 - "C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study."

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Atrial Natriuretic Factor (ANF)
3.	Adrenomedullin
4.	Biomarkers (Surrogate Marker)
5.	proAVP hormone
6.	proadrenomedullin
7.	Peroxiredoxins
8.	Natriuretic Peptides
9.	Intercellular Signaling Peptides and Proteins (Growth Factors)
10.	Brain Natriuretic Peptide (Natrecor)

Related Therapies and Procedures

1.	Resuscitation
2.	Radiofrequency Ablation